02.07.19 | news

FierceBiotech – Biotech HiberCell launches with $60M+ to combat cancer relapse and metastasis

HiberCell, a new startup focused on preventing cancer metastasis and relapse, launched Thursday with research out of Mount Sinai and $60.75 million from the likes of ARCH Venture Partners, Hillhouse Capital and 6 Dimensions Capital.

Read full story by Amirah Al Idrus here.